
Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million
Additional EUR 32.5 million will support clinical readiness and accelerate lead immuno-virotherapy candidates toward clinical proof-of-concept.
Search
All
Additional EUR 32.5 million will support clinical readiness and accelerate lead immuno-virotherapy candidates toward clinical proof-of-concept.
CAPZA Growth Tech invests in Web Geo Services to make it a leading international player in Geolocation Intelligence.
IDnow, a leading European Platform-as-a-Service provider for identity verification, announces its participation in the IDunion network, which aims to build an open ecosystem...
A crucial step has been taken by Belgian company A-Mansia Biotech, a co-spin-off of Wageningen University and UCLouvain. The European Food Safety Authority (EFSA) considers the...
Cegid, the specialist in business management solutions, plans to strengthen its position in the Payroll and Human Resources Management announces the acquisition of Talentsoft,...
Nexi, the leading PayTech in Europe, announces the strengthening of its partnership with Izicap, a Fintech specialized in innovative CRM & Loyalty solutions dedicated to Local...
Eligo Bioscience SA, a Paris, France-based microbiome engineering company, today announced that the Company presented preclinical data on its lead drug candidate, EB003, for...
Viva Wallet and PrestaShop have partnered to allow online merchants across Europe and the UK to accept fully localised payments in a few clicks, via the Viva Wallet...
Launchmetrics and Digital Brand Architects' campaign aims to drive Media Impact Value to influencers.